Watch Ticker

Syndax Pharmaceuticals, Inc.

Go to Syndax Pharmaceuticals, Inc. Website

$12.58

2.20 (21.19%)

Live

Previous Close

$10.38

Day Range

$11.9104 - $12.99

Previous Day Range

$9.68 - $10.47

Market Cap

$858.8 million USD

Day Vol.

6.8 million

Previous Day Vol.

3.2 million

Currency

USD

Primary Exchange

Nasdaq

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Sharon Klahre - Syndax to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 4, 2025

Syndax Pharmaceuticals will report its Q2 2025 financial results and host a conference call on August 4, 2025, providing an update on its innovative cancer therapies and ongoing clinical trials.

Related tickers: SNDX.

Read Full Article

N/A - Syndax Announces Participation in June Investor Conferences

Syndax Pharmaceuticals announced that it will present data on its cancer therapies Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) at the upcoming EHA 2025 conference.

Related tickers: SNDX.

Read Full Article

Trending Tickers

Please sign in to view